Skip to content

Foamix Pharmaceuticals Ltd.: filings

Every Foamix Pharmaceuticals Ltd. annual and quarterly report in the SEC record with the published financial measures it tagged, 13 filings, each linked to its SEC index.

Filing record ends 2020-03-12

The latest filing in this captured record is a 10-K filed 2020-03-12. No later filing is in the SEC companyfacts record captured on 2026-09-22. Foamix Pharmaceuticals Ltd. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-K2020-03-12fiscal FY 2019411140001178913-20-000792
10-Q2019-11-12fiscal Q3 201934860001178913-19-002668
10-Q2019-08-07fiscal Q2 201932840001178913-19-002091
10-Q2019-05-07fiscal Q1 201931640001178913-19-001382
10-K2019-02-28fiscal FY 2018361200001178913-19-000725
10-Q2018-11-07fiscal Q3 201831820001178913-18-002850
10-Q2018-08-08fiscal Q2 201828750001178913-18-002338
10-Q2018-05-08fiscal Q1 201827540001178913-18-001521
10-K2018-03-01fiscal FY 2017351200001178913-18-000738
10-K2018-02-27fiscal FY 2017351200001178913-18-000707
20-F2017-02-21fiscal FY 201632800001178913-17-000582
20-F2016-03-02fiscal FY 201531770001178913-16-004594
20-F2015-03-17fiscal FY 201428680001178913-15-000890

Inspect the source

Entity
Foamix Pharmaceuticals Ltd. / CIK 0001606645
Captured
SEC response SHA-256
b102c73a58c0072ed43450ed763cdf19a044a1d9e904bd75734fe9a636bd7360

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001606645.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))